Jump to contents

Researcher Information

last modified:2017/10/18

Professor INAZU Akihiro

Mail Laboratory Website

Faculty, Affiliation

Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences Clinical Laboratory Science
Professor, Graduate Course of Medical Science and Technology
Chairman of Clinical Laboratory Science
Director, Wellness Promotion Science Center

College and School Educational Field

Division of Health Sciences, Graduate School of Medical Science
Division of Health Sciences,Graduate School of Medical Science
Department of Laboratory Sciences,School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences


Akihiro INAZU Lab TEL:076-265-2607 FAX:076-234-4369

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor 1991
【Academic background(Bachelor's Degree)】
Kanazawa University 1986


Kanazawa Nishi Hospital(1992/01/01-1992/03/31)
Kanazawa University School of Health Sciences(1997/04/01-2005/03/31)
Kanazawa University Graduate School of Medical Science(2005/04/01-2009/03/31)

Year & Month of Birth


Academic Society






Metabolism、Cardiovascular medicine

Speciality Keywords

Lipid Metabolism, Atherosclerosis, Clinical Chemistry

Research Themes

Anti-atherogenicity of serum lipoproteins in CETP deficiency

Molecular genetics of dyslipidemia

Lipid lowering, HDL elevating therapy


  •  Akihiro Inazu The HDL handbook 3rd Edition Academic Press, Elsevier 2017/02/22
  •  High Density Lipoproteins, Dyslipidemia and Coronary Heart Disease Springer 95-102 2010/06


  •  HDL3 Cholesterol Levels in an Elderly Population Akihiro Inazu J Atheroscler Thromb 24 2017
  •  Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.  Tada H, Kawashiri MA, Yoshida T, Teramoto R, Nohara A, Konno T, Inazu A, Mabuchi H, Yamagishi M, Hayashi K. Circ J 80 2 512-8 2016/01/25
  •  Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects Ohtani, Rumiko; Inazu, Akihiro; Noji, Yoshihiro; Wakasugi, Takanobu; Miwa, Kenji; Tada, Hayato; Kawashiri, Masaaki; Noguchi, Tohru; Nohara, Atsushi; Kobayashi, Junji; Koizumi, Junji; Yamagishi, Masakazu; Mabuchi, Hiroshi Clinica Chimica Acta 413 42130 537-543 2012/03/22 
  •  Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP deficient patients Clinica Chimica Acta 402 1-2 19-24 2009/04
  •  Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Inazu A et al. ATHEROSCLEROSIS 196  953-957 2008/02

show all

  •  A low prevalence of coronary heart disease in subjects with increased high-density lipoprotein cholesterol levels including those with plasma cholesteryl ester transfer protein deficiency. Prev Med 27 5 659-667 1998/09
  •  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of HDL cholesterol JOURNAL OF CLINICAL INVESTIGATION 94 5 1872-1882 1994/11
  •  Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation NEW ENGLAND JOURNAL OF MEDICINE 323 18 1234-1238 1990/11
  •  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins.  Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Nature 342 6248 448-51 1989/11/23
  •  Anti-atherogenicity of HDL and the assay for HDL function Akihiro Inazu, Yutaka Takino 45 18-24 2016/01 
  •  Cholesteryl ester transfer protein and atherosclerosis. CURRENT OPINION IN LIPIDOLOGY 11 4 389-396 2000/08

Conference Presentations

  • Lp(a) molecular weight (MW) determination and relationship between Lp(a) MW and repeated number of kringle 4-2 of apo(a) gene(2016/03/19)
  • Basic Research Committee workshop Basic Study of Lipidomics and Evaluation of Anti-atherosclerotic Agents (conference:5th International Congress on Lipid Metabolism & Atherosclerosis (ICLA) 2016)(2016/09/09)

Arts and Fieldwork


Theme to the desired joint research

○HDL function assay development
○Lipid lowering agent, HDL modulating agent Pharmacogenetics

Grant-in-Aid for Scientific Research


Classes (Bachelors)

○Presentation and Debate (Freshman Seminar II)(2017)
○Environmental Hygiene-Laboratory and Field Work(2017)
○Presentation and Debate (Freshman Seminar II)(2017)
○Metabolism of Drugs and Xenobiotics(2017)
○Clinical Chemistry Laboratory(2017)
○Pathophysiology 2(2017)
○Clinial Practice of Clinical Chemistry(2017)
○Gene Diagnostics(2017)
○Clinical Chemistry(2017)
○Clinical Chemistry(2017)
○Clinical Chemistry(2017)
○Clinical Chemistry(2016)
○Clinial Practice of Clinical Chemistry(2016)
○Pathophysiology 2(2016)
○Gene Diagnostics(2016)
○Clinical Chemistry Laboratory(2016)

Classes (Graduate Schools)

○Molecular Biology for Laboratory Medicine:Research(2017)
○Adv. Mol. Biol. for Laboratory Medicine: Research(2017)
○Molecular Biology for Laboratory Medicine: Lecture(2017)
○Molecular Biology for Laboratory Medicine: Seminar(2017)
○An Introduction to Medical Laboratory Sciences:Lec(2017)
○Biological Information Analysis: Lecture(2017)
○Biological Information Analysis: Seminar(2017)
○Molecular Biology for Laboratory Medicine: Seminar(2016)
○Molecular Biology for Laboratory Medicine: Lecture(2016)
○Biological Information Analysis: Lecture(2016)
○Molecular Biology for Laboratory Medicine:Research(2016)
○Biological Information Analysis: Seminar(2016)
○An Introduction to Medical Laboratory Sciences:Lec(2016)
○Adv. Mol. Biol. for Laboratory Medicine: Research(2016)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top